Clinical effects and toxicity of interleukin-2 in patients with cancer
β Scribed by Michael T. Lotze; Yvedt L. Matory; Anthony A. Rayner; Stephen E. Ettinghausen; John T. Vetto; Claudia A. Seipp; Steven A. Rosenberg
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 938 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo
## Abstract ## Background. Factors that represent the potential for invasion and metastasis, such as matrix metalloproteinases (MMPs), could predict prognosis of cancer. Therefore, the authors studied plasma and tissue levels of MMPβ2 and MMPβ9 in oral cancer, the leading malignancy in India. ##